Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.160
+0.070 (6.42%)
At close: Oct 30, 2026, 4:00 PM EDT
1.120
-0.040 (-3.45%)
After-hours: Oct 30, 2026, 7:59 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $8.4 million as of October 30, 2026. It is the 42,375th most valuable company in the world and the 5,700th biggest in the United States. Its market cap has decreased by 47.42% in one year.
Market Cap
8.40M
Enterprise Value
1.72M
1-Year Change
-47.42%
Global Rank
Country Rank
#5,700 United States
Category
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $8.40M, a decrease of -98.67%. That is a compound annual growth rate of -53.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.40M | -17.24% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 8.91M |
| Tempest Therapeutics | 8.82M |
| Theriva Biologics | 8.58M |
| Ensysce Biosciences | 8.52M |
| Moleculin Biotech | 8.49M |
| CollPlant Biotechnologies | 8.32M |
| Palatin Technologies | 8.09M |
| Soligenix | 8.04M |